(Q41915302)

14 October 2017

Serious problems with antimalarial drugs (English)

1 reference

14 October 2017

0 references

Cook GC

1

1 reference

PubMed ID

3525683

14 October 2017

language of work or name

1 reference

1 July 1986

1 reference

14 October 2017

1 reference

14 October 2017

13

1 reference

14 October 2017

1

1 reference

14 October 2017

1-4

1 reference

Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies

14 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

The treatment of severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Complications of quinine poisoning.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Death and blindness due to overdose of quinine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Severe Hypoglycemia and Hyperinsulinemia in Falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Quinine and severe falciparum malaria in late pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Malaria chemoprophylaxis in expatriates in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Synergistic Antimalarial Activity of Pyrimethamine and Sulfadoxine against Plasmodium falciparum In Vitro *

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Does chloroquine contribute to the risk of serious adverse reactions to fansidar?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Amodiaquine induced agranulocytosis and liver damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992072-4

7 January 2021

10.1016/S0163-4453(86)92072-4

Identifiers

DOI

1 reference

14 October 2017

1 reference

PubMed ID

3525683